新維國際控股(08086.HK)擬折價配股 最多籌2146萬港元
格隆匯4月21日丨新維國際控股(08086.HK)宣佈,於2020年4月21日,公司擬向不少於六名承配人配售不超6.13億股新股份,佔經擴大後公司股份約16.67%,發行價每股0.035港元,較4月21日收市價0.04港元折讓約12.50%。
最高所得款項總額及所得款項淨額估計分別為約為2146萬港元及2073萬港元,擬用於償付2017年8月可換股債券及2017年12月可換股債券的本金及利息(倘公司被要求贖回該等可換股債券而不獲轉換),或用於償付集團到期的其他債務及負債(倘2017年8月可換股債券及2017年12月可換股債券乃獲轉換而不獲贖回)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.